Renaissance Capital logo

TCMD News

US IPO Weekly Recap: 4 IPOs price, Talend on top, Kadmon a flop

TLND

Four IPOs raised $315 million during the last week of the month, bringing July’s deal count to ten and signaling that IPO activity has not yet taken a vacation. Further evidence of a gradual tech IPO recovery materialized with cloud-based software provider Talend rocketing 42% higher on its debut, after pricing 13% above the midpoint.  On the other hand, cash-burning drug...read more

Profitable medical device maker Tactile Systems prices IPO at $10, cut from previous range

TCMD

Tactile Systems Technology, which sells at-home compression therapy devices for vascular swelling, raised $40 million by offering 4 million shares at $10, cut from the original $14-$16 range. Tactile Systems Technology plans to list on the Nasdaq under the symbol TCMD. Piper Jaffray, William Blair and Canaccord Genuity acted as lead managers on the deal....read more

Tactile Systems decreases proposed IPO deal size

TCMD

Tactile Systems Technology, which sells at-home compression therapy devices for vascular swelling, lowered the proposed deal size for its upcoming IPO on Wednesday. The Minneapolis, MN-based company now plans to raise $40 million by offering 4 million shares at a price of $10. Insiders intend to purchase $1 million worth of shares in the offering. The company had previously...read more

US IPO Week Ahead: Three profitable IPOs and a biotech look to raise $900 million

PTHN

Four IPOs are on the calendar to raise nearly $900 million in the week ahead. Three are profitable, including the fourth-largest offering of 2016 and two companies that grew more than 30% in the MRQ. A biotech with heavy insider buying will also come to market, another IPO in the most...read more